Cbd retail

The content below has been updated to reflect new positioning from the FDA. One of the biggest trends in self-care , health, and beauty today is the rise of cannabidiol products, popularly known as CBD. CBD does not produce any psychotropic or intoxicating effects — that is, CBD users do not experience the high that is associated with marijuana. CBD in retail is becoming more prevalent and many companies are struggling with the regulatory implications. CBD products are already being sold to treat chronic pain, anxiety, depression, and joint health with a host of other potential treatments touted by brands, consumers, and advocacy groups every day.

CBD in Retail: What Do Retailers Need to Know? [Update]

The content below has been updated to reflect new positioning from the FDA. One of the biggest trends in self-care , health, and beauty today is the rise of cannabidiol products, popularly known as CBD.

CBD does not produce any psychotropic or intoxicating effects — that is, CBD users do not experience the high that is associated with marijuana. CBD in retail is becoming more prevalent and many companies are struggling with the regulatory implications. CBD products are already being sold to treat chronic pain, anxiety, depression, and joint health with a host of other potential treatments touted by brands, consumers, and advocacy groups every day.

With the increase of these products in the marketplace, retailers are faced with the decision of joining the bandwagon or staying on the sidelines. Traditional health product retailers such as CVS have announced the debut of CBD wellness products at more than 1, of their stores.

The more interesting news is that non-health retailers are getting into the space as well — brands such as DSW and Nieman Marcus have announced that they will be including CBD in retail products this year. Most recently, Dollar General has announced it will include CBD products in more than 1, stores, crediting customer demand for adding it to their product mix. This means there is the potential for an influx of regulation in the area in the coming years.

David: Interest in the marketplace to introduce CBD-based products is certainly booming. The issuance of warning letters to companies marketing CBD products with unfounded claims is notably on the rise. These claims are often aimed at vulnerable populations seeking relief from conditions like AIDS wasting syndrome, epilepsy, neuropathic pain, spasticity associated with multiple sclerosis, and cancer and chemotherapy-induced nausea.

To date, the required clinical trials necessary to support the application for a new cannabis-based drugs simply have yet to occur. Without proper FDA approval, any CBD product whether it be marketed as a drug, supplement, or cosmetic cannot be verified as safe.

Consumers should question the quality, and therefore safety, of all CBD products at the moment. David: The FDA is actively working to evaluate the regulatory pathways for cannabis-containing and cannabis-derived products to be introduced to the marketplace. On May 31, , the FDA conducted a public hearing with the specific objective to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.

While the FDA did not intend for this hearing to produce any decisions or new positions on specific regulatory questions, the hearing was an important step in the continued evaluation of cannabis and cannabis-derived compounds in FDA-regulated products.

The FDA is narrowing their evaluation to the effects of cumulative exposure, how special populations might be affected, and how CBD may affect animals. David: The FDA is already evaluating the regulatory frameworks that apply to certain cannabis-derived products that are intended for non-drug uses, including how the FDA might consider updating its regulations, as well as whether potential legislation might be appropriate.

The information provided to the FDA to date has underscored the need for further scientific study about the safety and potential uses of CBD.

With the exception of one cannabis-derived drug, the FDA has approved no other marketing applications for specific treatments of disease or conditions using CBD. As such, consumers should remain vigilant and discuss all uses of CBD with their primary care physician.

This vigilance also applies to retailers offering CBD products. While product liability laws generally favor those not involved in manufacturing defective products, retailers can share in liability. In these cases, courts can turn to the retailer to pay damages to consumers affected by CBD products regardless of whether they were involved in its manufacture.

Given the current uncertainties in the industry, retailers would be very wise to carefully vet all CBD suppliers and evaluate the scope of their product liability insurance.

With regulatory oversight still being defined, brands should take a cautious but driven approach to CBD in retail. As consumers continue to explore this new trend, retailers can assess their current regulatory and quality strategies to identify potential areas of risk and shore up potential problem areas.

Laboratory Information Management System LIMS implementations can be challenging due to the cost, commitment of resources, and other competing priorities For Life Sciences organizations, there has never been a debate around the criticality of data quality and regulatory compliance. Sean Burke. Associate Partner Email LinkedIn. Contributors: David Patterson. What level of oversight currently exists for CBD products?

What are we likely to see the FDA do in the future? Subscribe to Clarkston's Insights. Life Sciences Consumer Products Retail. This field is for validation purposes and should be left unchanged. Blog Post. Related Insights View More. Blog Post Biotech Life Sciences. Subscribe to All Posts.

Iconic cannabis magazine High Times has tapped Peter Horvath, former CEO of a nationwide CBD retailer, to lead its pivot into marijuana retail. Read More. CBD Retail Conference Day 2: Satisfaction, Education Will Drive Retail Store CBD Sales. CBD Retail Conference Day 1: Speakers Talk Rising Numbers, Quality.

Cannabidiol CBD and hemp are trending in a big way in , and their presence is expected to only grow bigger. The Farm Bill legalized the production of hemp when it removed hemp from the definition of marijuana in the Controlled Substances Act. Because CBD is found in hemp, it effectively legalized CBD at the federal level, opening the door to an entire new product category. But as CBD and hemp become mainstream, hurdles continue to appear. One big one is that consumers are still confused about the products.

Please contact customerservices lexology. When it comes to CBD, recent momentum in the retail space, combined with some fear of being late to the party, is driving a desire for streamlined information and clear direction in regard to risks and logistics.

Educate ourselves — about you, about your needs, and about your priorities for self-care. Nanotechnology Described Nanotechnology is any technology that operates at scales of less than nanometers [ The CBD store has given me a chance to begin a new life of getting off of my pharmaceutical medication.

CBD & Hemp Market Cutting Traditional Retail’s Way

C-store sales of cannabidiol products have fallen due to statewide lockdowns. California-based company also makes CBD chocolates, tinctures, more. Agency outlines its efforts to gather new information and inform the public on its CBD findings. Has been descheduled from the federal list of controlled substances. Encourage competition, safety, medical facts and eradication of the black market.

CBD Retail Conference Day 2: Satisfaction, Education Will Drive Retail Store CBD Sales

In the following 4 chapters, you will quickly find the 25 most important statistics relating to "CBD retail in the United States". The most important key figures provide you with a compact summary of the topic of "CBD retail in the United States" and take you straight to the corresponding statistics. Feel free to contact us anytime using our contact form or visit our FAQ page. We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. Please see our privacy statement for details about how we use data. Single Accounts Corporate Solutions Universities. Popular Statistics Topics Markets. Published by Jan Conway , Apr 20,

CBD is popular not only in the cannabis community but also in the wellness space. Even stores that are unrelated to cannabis are starting to carry CBD products.

Due to the recent research and personal testimonials surrounding CBD, the market for CBD oil has expanded substantially. From our five years of experience in the CBD industry, we have gathered valuable information that will help guide you through the opening of a CBD store. The two major opportunities for CBD retail are online and in-store brick and mortar. This comprehensive guide will discuss both.

C-Stores Boost CBD Offerings Despite Pandemic Slowdown

The two-day virtual event featuring five speakers from the c-store retail and market analysis industries was sponsored by Forth CBD and Solari Hemp. Kay Tamillow, research director, Brightfield Group. Retail stores will be able to set themselves apart by easing fears and educating consumers face-to-face about CBD products and how they provide therapeutic remedies to mild pain, anxiety and chronic physical discomfort, among other ailments. And while topical CBD will garner the most sales dollars, other products like edible gummies, tnctures, CBD beverages, vape products and even pet CBD products will fit nicely into the c-store shelf space and customer demographic. Plus, with CBD ready-to-drink coffees and flavored fountain drinks among them, beverages offer multiple positioning opportunities across many dayparts — morning, afternoon, something to sip later in the evening. These products will become even more popular, said Tamillow, as distribution channels become more broad. Those numbers are a good bet to rise as hemp-CBD sees more mainstream acceptance. Together, consumers will have access to good products and sound education about how to use them. Satisfaction with a CBD product was the strongest driver of seeing it as a prevalent product in the future. In fact, more than half of satisfied CBD users, unsatisfied users and those who plan to use CBD are frequent convenience customers. Paup also noted that CBD users tend to enjoy food more and cook more. Product or promotion placement near electronics could pay off in CBD piggybacking on tech sales.

Every day comes with new questions, new answers, new problems, and new solutions, but the people who are getting into the market are dedicated to their products and their customers. Barstow St. CBD is short for cannabidoil, a derivative of hemp that people use to treat pain, sleeplessness, anxiety, and many other ailments. Buske is licensed by the state of Wisconsin to make his own hemp products, and carries a range of oils, cannabis flowers, and more. Just getting people in the door can be a challenge, he said.